Back
HFA Premium Access

Improving survival rates of patients with light-chain cardiac amyloidosis in recent years

Session: ePosters in myocardial disease 1
Topic: Clinical
Speaker: Doctor T. Nabeta (Sagamihara, JP)
Event: Heart Failure 2024

Congress Presentation

Add to my library

Like

About the speaker

Doctor Takeru Nabeta

Kitasato University School of Medicine, Sagamihara (Japan)
0 follower

5 more presentations in this session

SGLT2 inhibitors in wild-type transthyretin amyloid cardiomyopathy: what to expect?

Speaker: Doctor L. Pinheiro (Guimaraes, PT)

Access
Abstract
Slides
Video
Like
Thumbnail

Therapeutic value of spironolactone in wild-type transthyretin amyloid cardiomyopathy

Speaker: Doctor L. Pinheiro (Guimaraes, PT)

Access
Abstract
Slides
Video
Like
Thumbnail

Stabilizers of transthyretin in amyloid cardiomyopathy: a systematic review and meta-analysis.

Speaker: Ms L. Burgos (Buenos Aires, AR)

Access
Abstract
Slides
Video
Like
Thumbnail

Incidence and progression of left ventricular involvement in patients with arrythmogenic cardiomyopathy

Speaker: Doctor A. Diaz Exposito (Malaga, ES)

Access
Abstract
Slides
Video
Like
Thumbnail

Left ventricular non compaction in sub-saharan african adults

Speaker: Doctor N. GAYE (Dakar, SN)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

ePosters in myocardial disease 1

Speakers: Doctor T. Nabeta, Doctor L. Pinheiro, Doctor L. Pinheiro, Ms L. Burgos, Doctor A. Diaz Exposito...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources